Concepts (101)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| EGF Family of Proteins | 1 | 2014 | 17 | 0.490 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2016 | 756 | 0.480 |
Why?
|
| Wnt Signaling Pathway | 1 | 2014 | 57 | 0.470 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2014 | 108 | 0.460 |
Why?
|
| ErbB Receptors | 1 | 2014 | 239 | 0.430 |
Why?
|
| Breast Neoplasms | 3 | 2016 | 1536 | 0.370 |
Why?
|
| Sodium-Calcium Exchanger | 5 | 2009 | 69 | 0.330 |
Why?
|
| NAD | 1 | 2022 | 73 | 0.200 |
Why?
|
| Quinazolines | 1 | 2019 | 70 | 0.170 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2019 | 41 | 0.170 |
Why?
|
| Cell Line, Tumor | 4 | 2019 | 1851 | 0.160 |
Why?
|
| Pyrazoles | 1 | 2019 | 190 | 0.160 |
Why?
|
| Piperazines | 1 | 2019 | 206 | 0.150 |
Why?
|
| Liver Neoplasms | 1 | 2022 | 334 | 0.150 |
Why?
|
| Cell Cycle Proteins | 1 | 2019 | 230 | 0.150 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2019 | 411 | 0.150 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2019 | 331 | 0.140 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 468 | 0.140 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2016 | 33 | 0.130 |
Why?
|
| Estrogen Receptor alpha | 1 | 2016 | 65 | 0.130 |
Why?
|
| Up-Regulation | 4 | 2016 | 682 | 0.130 |
Why?
|
| Breast | 1 | 2016 | 137 | 0.120 |
Why?
|
| Amphiregulin | 1 | 2014 | 19 | 0.120 |
Why?
|
| Estrogens | 1 | 2016 | 173 | 0.120 |
Why?
|
| Histone Acetyltransferases | 1 | 2014 | 13 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2014 | 54 | 0.120 |
Why?
|
| Nuclear Proteins | 1 | 2016 | 271 | 0.120 |
Why?
|
| Oncogenes | 1 | 2014 | 71 | 0.120 |
Why?
|
| Myocardium | 3 | 2009 | 1204 | 0.110 |
Why?
|
| Heart | 3 | 2009 | 850 | 0.110 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 3 | 2009 | 134 | 0.100 |
Why?
|
| Thiourea | 1 | 2009 | 16 | 0.090 |
Why?
|
| Gene Expression Regulation | 2 | 2007 | 1293 | 0.080 |
Why?
|
| Myocytes, Cardiac | 3 | 2009 | 442 | 0.080 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2006 | 43 | 0.070 |
Why?
|
| Cardiomegaly | 1 | 2007 | 213 | 0.070 |
Why?
|
| Cats | 4 | 2009 | 292 | 0.070 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2006 | 328 | 0.060 |
Why?
|
| Female | 5 | 2019 | 38074 | 0.050 |
Why?
|
| Voltage-Dependent Anion Channels | 1 | 2022 | 40 | 0.050 |
Why?
|
| Molecular Docking Simulation | 1 | 2022 | 78 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2002 | 250 | 0.050 |
Why?
|
| Adenosine Triphosphate | 1 | 2022 | 314 | 0.050 |
Why?
|
| Cell Proliferation | 2 | 2016 | 1174 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 3 | 2007 | 615 | 0.040 |
Why?
|
| Humans | 5 | 2022 | 68618 | 0.040 |
Why?
|
| Tumor Burden | 1 | 2019 | 132 | 0.040 |
Why?
|
| Thiophenes | 1 | 2019 | 76 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2019 | 260 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 304 | 0.040 |
Why?
|
| Benzimidazoles | 1 | 2019 | 128 | 0.040 |
Why?
|
| Animals | 6 | 2019 | 20881 | 0.040 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2019 | 332 | 0.040 |
Why?
|
| Mitochondria | 1 | 2022 | 643 | 0.040 |
Why?
|
| Mice | 3 | 2019 | 8474 | 0.040 |
Why?
|
| Chromatin | 1 | 2016 | 76 | 0.030 |
Why?
|
| Genes, Reporter | 2 | 2006 | 191 | 0.030 |
Why?
|
| Adenoviridae | 2 | 2006 | 295 | 0.030 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2014 | 30 | 0.030 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2014 | 19 | 0.030 |
Why?
|
| Spheroids, Cellular | 1 | 2014 | 45 | 0.030 |
Why?
|
| Base Sequence | 2 | 2006 | 1015 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2014 | 219 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 196 | 0.030 |
Why?
|
| Neoplastic Stem Cells | 1 | 2014 | 84 | 0.030 |
Why?
|
| RNA Interference | 1 | 2014 | 266 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2014 | 235 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2014 | 852 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2014 | 498 | 0.030 |
Why?
|
| Protein Binding | 1 | 2014 | 1027 | 0.020 |
Why?
|
| Calcium Channels, L-Type | 1 | 2009 | 34 | 0.020 |
Why?
|
| Sodium-Hydrogen Exchangers | 1 | 2009 | 43 | 0.020 |
Why?
|
| Prognosis | 1 | 2014 | 2093 | 0.020 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2009 | 153 | 0.020 |
Why?
|
| Calcium Channel Blockers | 1 | 2009 | 138 | 0.020 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2009 | 98 | 0.020 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2009 | 189 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2009 | 791 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2006 | 95 | 0.020 |
Why?
|
| Transgenes | 1 | 2006 | 92 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2006 | 52 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2006 | 176 | 0.020 |
Why?
|
| Phenylephrine | 1 | 2005 | 61 | 0.020 |
Why?
|
| Luciferases | 1 | 2005 | 105 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2005 | 204 | 0.020 |
Why?
|
| Imidazoles | 1 | 2005 | 175 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2006 | 1447 | 0.010 |
Why?
|
| MAP Kinase Signaling System | 1 | 2005 | 247 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2006 | 1033 | 0.010 |
Why?
|
| Pyridines | 1 | 2005 | 261 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2005 | 742 | 0.010 |
Why?
|
| Muscle Cells | 1 | 2002 | 30 | 0.010 |
Why?
|
| DNA | 1 | 2005 | 597 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2006 | 1664 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2005 | 659 | 0.010 |
Why?
|
| Mutation | 1 | 2006 | 1213 | 0.010 |
Why?
|
| Time Factors | 1 | 2009 | 4655 | 0.010 |
Why?
|
| Cell Line | 1 | 2005 | 1752 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2006 | 2550 | 0.010 |
Why?
|
| Rats | 1 | 2006 | 5300 | 0.010 |
Why?
|
| Male | 1 | 2006 | 37321 | 0.000 |
Why?
|